Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.

The new nomenclature of SLDs is useful for obtaining a better understanding of liver pathologies and for providing valuable insights into predictive factors and the dynamic interplay of diseases. FLI may be a noninvasive predictive marker for detection of SLDs.